2023 annual financial data
Takeda Pharmaceutical 2023 Net margin
Direct answer
Net margin was 7.87%.
Operating income was 490,505,000,000 JPY and net income was 317,017,000,000 JPY.
Operating cash flow was 977,156,000,000 JPY.
Get free Takeda Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,027,478,000,000 JPY
- Operating income
- 490,505,000,000 JPY
- Net income
- 317,017,000,000 JPY
- Operating cash flow
- 977,156,000,000 JPY
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Takeda Pharmaceutical financial years